Title | Type | SJR | H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | %Female (2001) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Differentiation | journal | 0.997 Q1 | 107 | 61 | 118 | 3230 | 225 | 118 | 1.83 | 52.95 | 35.32 | |
52 | Mini-Reviews in Medicinal Chemistry | journal | 107 | 38 | 0 | 3149 | 0 | 0 | 0.00 | 82.87 | 26.76 | ||
53 | Molecular Carcinogenesis | journal | 1.521 Q1 | 107 | 73 | 292 | 3045 | 967 | 289 | 3.41 | 41.71 | 34.42 | |
54 | Oncology | journal | 0.814 Q2 | 107 | 120 | 315 | 3889 | 700 | 306 | 2.10 | 32.41 | 21.65 | |
55 | Journal of Immunotherapy | journal | 0.874 Q2 | 106 | 37 | 142 | 1157 | 355 | 135 | 2.31 | 31.27 | 35.98 | |
56 | Cytotherapy | journal | 0.273 Q3 | 105 | 56 | 104 | 1610 | 70 | 91 | 0.67 | 28.75 | 34.67 | |
57 | Current Opinion in Oncology | journal | 1.076 Q1 | 104 | 102 | 333 | 4271 | 847 | 302 | 2.62 | 41.87 | 27.89 | |
58 | Current Cancer Drug Targets | journal | 103 | 16 | 0 | 1772 | 0 | 0 | 0.00 | 110.75 | 21.43 | ||
59 | Seminars in Radiation Oncology | journal | 1.263 Q1 | 103 | 39 | 135 | 2168 | 421 | 125 | 2.96 | 55.59 | 29.27 | |
60 | Anti-Cancer Drugs | journal | 0.514 Q3 | 102 | 131 | 370 | 4095 | 644 | 369 | 1.65 | 31.26 | 21.81 | |
61 | Cancer journal (Sudbury, Mass.) | journal | 1.148 Q1 | 102 | 90 | 279 | 3702 | 615 | 211 | 1.94 | 41.13 | 26.09 | |
62 | Leukemia and Lymphoma | journal | 0.487 Q3 | 102 | 319 | 898 | 10405 | 1304 | 889 | 1.38 | 32.62 | 32.18 | |
63 | Angiogenesis | journal | 0.638 Q2 | 101 | 30 | 75 | 1090 | 110 | 75 | 1.54 | 36.33 | 38.10 | |
64 | Tumor Biology | journal | 0.516 Q3 | 101 | 53 | 149 | 1670 | 197 | 147 | 1.08 | 31.51 | 21.54 | |
65 | Cancer Gene Therapy | journal | 0.945 Q2 | 99 | 114 | 287 | 4021 | 919 | 285 | 3.01 | 35.27 | 26.92 | |
66 | Gastric Cancer | journal | 0.173 Q4 | 99 | 37 | 39 | 932 | 15 | 36 | 0.38 | 25.19 | 7.06 | |
67 | Breast | journal | 0.236 | 98 | 146 | 232 | 3523 | 119 | 212 | 0.39 | 24.13 | 34.21 | |
68 | International Journal of Hyperthermia | journal | 0.475 Q3 | 98 | 40 | 135 | 1265 | 149 | 126 | 1.09 | 31.63 | 23.88 | |
69 | Nuclear Medicine and Biology | journal | 0.749 Q2 | 98 | 120 | 372 | 3536 | 670 | 368 | 1.78 | 29.47 | 23.25 | |
70 | Leukemia Research | journal | 0.539 Q3 | 96 | 156 | 459 | 4767 | 648 | 415 | 1.39 | 30.56 | 35.18 | |
71 | Japanese Journal of Clinical Oncology | journal | 0.334 Q3 | 95 | 141 | 458 | 2259 | 331 | 392 | 0.59 | 16.02 | 10.06 | |
72 | Journal of Oral Pathology and Medicine | journal | 0.598 Q2 | 95 | 100 | 248 | 3006 | 430 | 245 | 1.72 | 30.06 | 30.00 | |
73 | Journal of the National Cancer Institute. Monographs | journal | 1.212 Q1 | 95 | 46 | 77 | 1192 | 279 | 73 | 3.16 | 25.91 | 32.14 | |
74 | Cancer Investigation | journal | 0.666 Q2 | 93 | 100 | 296 | 5254 | 453 | 254 | 1.50 | 52.54 | 26.80 | |
75 | Asian Pacific Journal of Cancer Prevention | journal | 0.159 Q4 | 91 | 48 | 49 | 1447 | 32 | 40 | 0.65 | 30.15 | 28.71 | |
76 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.412 Q3 | 90 | 138 | 415 | 2943 | 528 | 404 | 1.21 | 21.33 | 21.99 | |
77 | Medical Oncology | journal | 0.432 Q3 | 90 | 38 | 159 | 949 | 232 | 154 | 1.43 | 24.97 | 34.08 | |
78 | European Journal of Cancer Prevention | journal | 0.647 Q2 | 88 | 90 | 253 | 2408 | 496 | 229 | 1.80 | 26.76 | 33.62 | |
79 | Cancer Epidemiology | journal | 0.637 Q2 | 86 | 64 | 206 | 149 | 350 | 205 | 1.53 | 2.33 | 30.64 | |
80 | Oncology | journal | 0.376 Q3 | 83 | 259 | 916 | 2375 | 893 | 879 | 0.94 | 9.17 | 24.23 | |
81 | Sub-Cellular Biochemistry | journal | 0.735 Q2 | 81 | 0 | 125 | 0 | 185 | 125 | 1.01 | 0.00 | 0.00 | |
82 | Cancer Cell International | journal | 80 | 3 | 0 | 177 | 0 | 0 | 0.00 | 59.00 | 40.00 | ||
83 | Clinical Breast Cancer | journal | 0.179 Q4 | 80 | 49 | 38 | 1460 | 11 | 36 | 0.29 | 29.80 | 33.65 | |
84 | Melanoma Research | journal | 0.864 Q2 | 80 | 85 | 238 | 2390 | 480 | 225 | 1.90 | 28.12 | 32.43 | |
85 | Cancer Genetics and Cytogenetics | journal | 0.639 Q2 | 78 | 247 | 821 | 6362 | 1212 | 738 | 1.49 | 25.76 | 42.60 | |
86 | Molecular Imaging and Biology | journal | 0.339 Q3 | 78 | 0 | 132 | 0 | 93 | 132 | 0.64 | 0.00 | 0.00 | |
87 | Prostate Cancer and Prostatic Diseases | journal | 0.280 Q3 | 78 | 45 | 251 | 1191 | 98 | 226 | 0.35 | 26.47 | 15.27 | |
88 | Oncology Research | journal | 0.682 Q2 | 76 | 33 | 346 | 1011 | 722 | 343 | 1.96 | 30.64 | 34.10 | |
89 | Clinical Lung Cancer | journal | 0.165 Q4 | 74 | 54 | 39 | 1472 | 8 | 29 | 0.21 | 27.26 | 29.03 | |
90 | In Vivo | journal | 0.433 | 72 | 84 | 298 | 2416 | 332 | 296 | 1.08 | 28.76 | 25.84 | |
91 | Advances in Biological Regulation | journal | 1.111 Q1 | 69 | 22 | 68 | 1070 | 161 | 67 | 2.47 | 48.64 | 31.46 | |
92 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.492 Q3 | 68 | 58 | 170 | 1918 | 256 | 152 | 1.53 | 33.07 | 27.49 | |
93 | Familial Cancer | journal | 67 | 32 | 0 | 867 | 0 | 0 | 0.00 | 27.09 | 37.33 | ||
94 | Cancer Treatment and Research | journal | 0.363 Q3 | 65 | 73 | 139 | 7349 | 93 | 139 | 0.75 | 100.67 | 28.80 | |
95 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.162 Q4 | 65 | 46 | 32 | 1290 | 14 | 31 | 0.44 | 28.04 | 27.72 | |
96 | Recent Results in Cancer Research | book series | 0.682 Q2 | 63 | 25 | 213 | 270 | 368 | 213 | 1.94 | 10.80 | 26.60 | |
97 | Clinical and Translational Oncology | journal | 0.105 Q4 | 61 | 68 | 56 | 1671 | 8 | 38 | 0.14 | 24.57 | 38.79 | |
98 | Pathology and Oncology Research | journal | 0.426 Q3 | 61 | 44 | 148 | 1271 | 153 | 148 | 0.91 | 28.89 | 39.77 | |
99 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 59 | 16 | 17 | 1465 | 12 | 17 | 0.80 | 91.56 | 25.00 | ||
100 | Tumori | journal | 0.254 Q3 | 59 | 312 | 485 | 4761 | 317 | 476 | 0.51 | 15.26 | 32.13 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®